Number of FDA new molecular entity approvals in 2020 similar to 2019
Despite the COVID19 pandemic, the FDA
approved 47 new molecular entities in 2020
including one for ophthalmology, compared with 48 in 2019, according to a speaker at the virtual Ophthalmology Innovation Summit Year in Review meeting.
Cornea Products Market to Grow an Estimated 6.1 Percent Through 2025
Market Scope’s “2020 Cornea Products Market
Report” was published in November
Inspecs Announces Acquisition of Eschenbach
Inspecs Group, a leading designer, manufacturer
and distributor of eyewear frames, announced that
it has conditionally agreed to acquire all of the equity interests in Eschenbach Holding GmbH for €94.85 million (approximately £84.7 million).
SLT as primary glaucoma treatment may offer reduced cost, better efficacy than eye drops
“With SLT laser, you simply treat the patient,
and the rest is history” Nathan Radcliffe, MD
Japanese hospital conducts world's 1st iPS transplant of visual cells
A Japanese hospital said it has performed the
world's first clinical trial of a transplant of visual cells
derived from induced pluripotent stem cells, or iPS cells, to treat a patient with pigmentary retinal degeneration.
WVU and Pitt team up for laser trial to treat glaucoma
Dr. Tony Realini, professor of ophthalmology and glaucoma
specialist at WVU, will be the principal investigator of
a $15.2 million study on how a treatment called selective laser trabeculoplasty (SLT).